Literature DB >> 30644026

Transcultural validation of the 5-Item Dry Eye Questionnaire for the Mexican population.

Jaime D Martinez1,2,3, Anat Galor4,2, Guillermo Amescua2, Nallely Ramos-Betancourt1,3, Francisco Beltrán1,3, Alejandro Babayán Sosa5,3, Concepción Santacruz Valdés6,3, Cecilia Ramírez-Assad7, Elsa Mora Juárez8, Everardo Hernández-Quintela9,10,11.   

Abstract

PURPOSE: To translate and validate a Spanish-language adaptation of the 5-Item Dry Eye Questionnaire for the Mexican population.
METHODS: Based on the MAPI Institute guidelines, the linguistic validation procedures consisted of four steps. Every step was reviewed by the committee. The translated validated questionnaire was applied to 25 Mexican subjects. The questionnaires were completed by the same subjects at three time points, 8 h apart on the same day and then 3 days later. Sensitivity and specificity of the DEQ-5 to predict DE signs was subsequently estimated in 200 patients see in the Asociación para Evitar la Ceguera ophthalmology clinic.
RESULTS: During the forward translation step analysis, the committee decided to change the severity scale, as the words "constantly" and "frequently" are synonymous in Spanish, so it was modified by changing "constantly" to "always" for better understanding. Overall, the intra-test intra-class correlation coefficient from tests administered on the same day was 0.9 (95% CI 0.77-0.95, p = 0.0005). The intra-test intra-class correlation coefficient from tests administered 3 days apart was 0.9 (95% CI 0.88-0.97, p = 0.0005). When applying the questionnaire to 200 patients seen in an eye clinic, we found a sensitivity of 76% and a specificity of 31% for a DEQ-5 score of ≥ 6, against 2 or more positive signs of dry eye.
CONCLUSION: MAPI methodology proved to be a reliable strategy for the transcultural Dry Eye Questionnaire for translation from English to Spanish for the Mexican population.

Entities:  

Keywords:  Dry eye disease; Dry eye questionnaire; Ocular surface disease

Year:  2019        PMID: 30644026     DOI: 10.1007/s10792-018-01068-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  28 in total

1.  Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study.

Authors:  Bo Guo; Peng Lu; Xiaoming Chen; Wenfang Zhang; Rongting Chen
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

Review 2.  TFOS DEWS II Sex, Gender, and Hormones Report.

Authors:  David A Sullivan; Eduardo M Rocha; Pasquale Aragona; Janine A Clayton; Juan Ding; Blanka Golebiowski; Ulrike Hampel; Alison M McDermott; Debra A Schaumberg; Sruthi Srinivasan; Piera Versura; Mark D P Willcox
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 3.  TFOS DEWS II Epidemiology Report.

Authors:  Fiona Stapleton; Monica Alves; Vatinee Y Bunya; Isabelle Jalbert; Kaevalin Lekhanont; Florence Malet; Kyung-Sun Na; Debra Schaumberg; Miki Uchino; Jelle Vehof; Eloy Viso; Susan Vitale; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  Epidemiology of discordance between symptoms and signs of dry eye.

Authors:  Erin S Ong; Elizabeth R Felix; Roy C Levitt; William J Feuer; Constantine D Sarantopoulos; Anat Galor
Journal:  Br J Ophthalmol       Date:  2017-08-18       Impact factor: 4.638

5.  [Translation and validation of ocular surface disease index to Portuguese].

Authors:  Adriano Mauricio Prigol; Marília Barreto Tenório; Roberta Matschinske; Marcelo Luiz Gehlen; Thelma Skare
Journal:  Arq Bras Oftalmol       Date:  2012 Jan-Feb       Impact factor: 0.872

6.  Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women.

Authors:  Biljana Miljanović; Komal A Trivedi; M Reza Dana; Jeffery P Gilbard; Julie E Buring; Debra A Schaumberg
Journal:  Am J Clin Nutr       Date:  2005-10       Impact factor: 7.045

7.  Prevalence of dry eye in the normal population in Jeddah, Saudi Arabia.

Authors:  Amal Bukhari; Radwan Ajlan; Husain Alsaggaf
Journal:  Orbit       Date:  2009

8.  Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): Discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses.

Authors:  Robin L Chalmers; Carolyn G Begley; Barbara Caffery
Journal:  Cont Lens Anterior Eye       Date:  2010-01-25       Impact factor: 3.077

9.  Key questions in a dry eye history.

Authors:  C W McMonnies
Journal:  J Am Optom Assoc       Date:  1986-07

10.  Prevalence of dry eye among adult Chinese in the Beijing Eye Study.

Authors:  Y Jie; L Xu; Y Y Wu; J B Jonas
Journal:  Eye (Lond)       Date:  2008-02-29       Impact factor: 3.775

View more
  4 in total

1.  Pregabalin Failed to Prevent Dry Eye Symptoms after Laser-Assisted in Situ Keratomileusis (LASIK) in a Randomized Pilot Study.

Authors:  Anat Galor; Sneh Patel; Leslie R Small; Adriana Rodriguez; Michael J Venincasa; Stephen E Valido; William Feuer; Roy C Levitt; Constantine D Sarantopoulos; Elizabeth R Felix
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

2.  Ocular Surface Disease Index© and the five-item dry eye questionnaire: A comparison in Indian patients with dry eye disease.

Authors:  Samrat Chatterjee; Deepshikha Agrawal; Pravda Chaturvedi
Journal:  Indian J Ophthalmol       Date:  2021-09       Impact factor: 1.848

3.  A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel.

Authors:  Alejandro Rodriguez-Garcia; Alejandro Babayan-Sosa; Arturo Ramirez-Miranda; Concepcion Santa Cruz-Valdes; Everardo Hernandez-Quintela; Julio C Hernandez-Camarena; Nallely Ramos-Betancourt; Regina Velasco-Ramos; Raul E Ruiz-Lozano
Journal:  Clin Ophthalmol       Date:  2022-04-28

4.  Ocular Pain Symptoms in Individuals With and Without a History of Refractive Surgery: Results From a Cross-Sectional Survey.

Authors:  Brandon S Baksh; Melina Morkin; Elizabeth Felix; Carol L Karp; Anat Galor
Journal:  Cornea       Date:  2022-01-01       Impact factor: 3.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.